Easy to Use Solution with PCR Performance1
The Novodiag C. difficile assay, performed with the Novodiag® System, is a cartridge-based molecular test for qualitative detection of pathogenic Clostridium difficile strains producing toxin B. The test uses stool samples without preservatives or collected in FecalSwabTM.*
Smart Simplicity in On-demand Testing
Pathogenic Strains1
The assay detects the gene tcdB, coding for toxin B, a virulence factor expressed by most pathogenic C. difficile strains.
Rapid & Safe Results
The Novodiag rapid ‘sample-in, result-out’ system, allows the fully automated detection of C. difficile in less than 1 hour.2
User-Friendly Science
The user-friendly nature of the system means that the Novodiag System can be easily implemented in decentralised settings as well as high risk and hard to reach areas without the need for highly trained personnel.
Simplify & Scale the Future of Diagnostics
The Novodiag C. difficile Assay is part of the Hologic Molecular Scalable Solution, a portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient rapid result to population level screening.
User-friendly Precision Engineering
A simple and fast way to pinpoint patients most at risk with on-demand testing. The small, quiet, stackable, fully-automated system combines easy-to-use functionality with PCR performance, to bring clinical confidence closer to patients.
A Practical Workflow
Step 1
Add sample to cartridge and close with the cap
Step 2
Scan cartridge and sample ID
Step 3
Insert cartridge and start test
Step 4
Fully-automated results and clear reporting, LIS connectivity
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
*This product is not a product of Hologic and it is manufactured by Copan Italia SpA
- Novodiag® C. difficile Instructions for Use V7-0 – May 2022, Espoo, FINLAND; Mobidiag Ltd. 2022
- Verification Report Novodiag® C. difficile V2-0
Safety Data Sheets
Package Inserts
Related Products
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
EC Representative Information wherever applicable